
Catabasis Pharmaceuticals, Inc.
USD8.54
-0.64 (-6.97%)
CEO
Jill Milne
IPO Date
2015-06-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$10.07
Prev. Close
$9.18
Day Low
$8.48
Day High
$9.21
52W Low
$1.25
52W High
$10.26
Market Cap
$0.23B
Volume
0.10M
| 2 Nov 2020 |
| Wedbush |
| Outperform |
| Neutral |
| downgrade |
| 27 Oct 2020 | Oppenheimer | Outperform | Perform | downgrade |
| 27 Oct 2020 | HC Wainwright & Co. | Buy | Neutral | downgrade |
| 1 Oct 2020 | HC Wainwright & Co. | Buy | Buy | maintain |
| 10 Aug 2018 | Citigroup | Buy | Buy | maintain |
| 20 Mar 2018 | Wedbush | Outperform | Outperform | maintain |
| 20 Nov 2017 | Citigroup | Neutral | Buy | upgrade |